Incannex Healthcare (IXHL) Net Income (2022 - 2026)
Incannex Healthcare (IXHL) posted quarterly Net Income of -$3.9 million for Q1 2026, up 2.14% year-on-year from -$3.8 million in Q1 2025, and up 40.45% on a QoQ basis from -$6.5 million in Q4 2025.
Incannex Healthcare (IXHL) Net Income (2022 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Net Income for 5 consecutive years, with -$3.9 million the latest figure, recorded in Q1 2026.
- Quarterly Net Income rose 2.14% year-over-year to -$3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$48.4 million (down 122.97% YoY) and the FY2025 annual result came in at -$46.9 million, down 154.0% from the prior year.
- Net Income rose to -$3.9 million in Q1 2026 per IXHL's latest filing, from -$6.5 million in the prior quarter.
- Over the last five years, Net Income for IXHL reached as high as -$726000.0 in Q3 2023 and fell as low as -$31.6 million in Q2 2025.
- A 5-year average of -$6.6 million and a median of -$5.3 million in 2023 frame the typical range for Net Income.
- Annual changes were most pronounced in 2024 — Net Income slumped 646.56% — and 2025, when it soared 34.21%.
- Year by year, Net Income stood at -$2.9 million in 2022, then tumbled by 79.61% to -$5.2 million in 2023, then declined by 12.46% to -$5.9 million in 2024, then retreated by 10.64% to -$6.5 million in 2025, then surged by 40.45% to -$3.9 million in 2026.
- According to Business Quant data, Net Income over the past three periods registered -$3.9 million, -$6.5 million, and -$6.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | -3.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.88 Mn |
| Dec 31, 2025 | -6.52 Mn |
| Sep 30, 2025 | -6.41 Mn |
| Jun 30, 2025 | -31.60 Mn |
| Mar 31, 2025 | -3.97 Mn |
| Dec 31, 2024 | -5.89 Mn |
| Sep 30, 2024 | -5.42 Mn |
| Jun 30, 2024 | -6.43 Mn |
| Mar 31, 2024 | -6.03 Mn |
| Dec 31, 2023 | -5.24 Mn |
| Sep 30, 2023 | -726,000.00 |
| Jun 30, 2023 | -4.17 Mn |
| Mar 31, 2023 | -3.57 Mn |
| Dec 31, 2022 | -2.92 Mn |